Decalin-Containing Tetramic Acids and 4-Hydroxy-2-pyridones with Antimicrobial and Cytotoxic Activity from the Fungus Coniochaeta cephalothecoides Collected in Tibetan Plateau (Medog).

New tetramic acid derivatives, (±)-conipyridoins A-D (1-4), conipyridoins E (5) and F (6), and new 4-hydroxy-2-pyridone alkaloids (±)-didymellamide E (7), (+)-didymellamide B (8), (+)-N-hydroxyapiosporamide (9), and didymellamides F-H (10-12) were isolated and identified from the solid culture of the fungus Coniochaeta cephalothecoides. Chiral resolution of 1, 2, 3, 4, and 7 gave five pairs of enantiomers: 1a/1b, 2a/2b, 3a/3b, 4a/4b, and 7a/7b, respectively. Stereochemistry of 1a and 1b, and 2a and 2b was established and confirmed by the single-crystal X-ray diffraction and electronic circular dichroism (ECD) methods. Absolute configuration in 3a, 3b, 4a, 4b, 7a, and 7b was assigned by ECD calculations. Compounds 1-6 possess an unprecedented chemical skeleton featuring a decalin ring and a tetramic acid moiety. Compound 11 significantly inhibited the growth of Candida albicans and Aspergillus fumigatus with minimum inhibitory concentration (MIC) of 3.13 and 1.56 μM, respectively, and was further confirmed to be a new chitin synthesis inhibitor. Compound 5 exhibited the strongest activity against the growth of both Staphylococcus aureus and MRSA with MIC value of 0.97 μM. In the light of a co-occurrence of 3-acyl tetramic acids and biogenetically related pyridine alkaloids, the biosynthetic pathway for 1-12 was postulated.

[1]  Yuying Zhang,et al.  Bioactive Pyridone Alkaloids from a Deep-Sea-Derived Fungus Arthrinium sp. UJNMF0008 , 2018, Marine drugs.

[2]  M. Kołaczkowski,et al.  Drug resistance mechanisms and their regulation in non-albicans Candida species. , 2016, The Journal of antimicrobial chemotherapy.

[3]  T. Chiller,et al.  The Global Burden of Fungal Diseases. , 2016, Infectious disease clinics of North America.

[4]  L. Botana,et al.  Gambierone, a Ladder-Shaped Polyether from the Dinoflagellate Gambierdiscus belizeanus. , 2015, Organic letters.

[5]  Xingzhong Liu,et al.  Gloeophyllins A-J, Cytotoxic Ergosteroids with Various Skeletons from a Chinese Tibet Fungus Gloeophyllum abietinum. , 2015, Organic letters.

[6]  David W. Denning,et al.  How to bolster the antifungal pipeline , 2015, Science.

[7]  I. Wilson,et al.  Kexin-like endoprotease KexB is required for N-glycan processing, morphogenesis and virulence in Aspergillus fumigatus. , 2015, Fungal genetics and biology : FG & B.

[8]  Xiaoyi Wei,et al.  Arthpyrones A-C, pyridone alkaloids from a sponge-derived fungus Arthrinium arundinis ZSDS1-F3. , 2015, Organic Letters.

[9]  L. Samaranayake,et al.  In pursuit of the ideal antifungal agent for Candida infections: high-throughput screening of small molecules. , 2014, Drug discovery today.

[10]  T. Roemer,et al.  Antifungal drug development: challenges, unmet clinical needs, and new approaches. , 2014, Cold Spring Harbor perspectives in medicine.

[11]  L. Cai,et al.  Coicenals A-D, four new diterpenoids with new chemical skeletons from the plant pathogenic fungus Bipolaris coicis. , 2013, Organic letters.

[12]  W. Mousa,et al.  The Diversity of Anti-Microbial Secondary Metabolites Produced by Fungal Endophytes: An Interdisciplinary Perspective , 2013, Front. Microbiol..

[13]  T. Sugita,et al.  Pyridone alkaloids from a marine-derived fungus, Stagonosporopsis cucurbitacearum, and their activities against azole-resistant Candida albicans. , 2013, Journal of natural products.

[14]  Andrew M. Piggott,et al.  Brevianamides with antitubercular potential from a marine-derived isolate of Aspergillus versicolor. , 2012, Organic letters.

[15]  D. Krysan,et al.  Antifungal Drug Discovery: Something Old and Something New , 2012, PLoS pathogens.

[16]  D. Denning,et al.  Tackling Human Fungal Infections , 2012, Science.

[17]  Hui Guo,et al.  Antimicrobial Antioxidant Daucane Sesquiterpenes from Ferula hermonis Boiss , 2012, Phytotherapy research : PTR.

[18]  B. Zhai,et al.  Recent progress on antifungal drug development. , 2011, Current pharmaceutical biotechnology.

[19]  A. Trabocchi,et al.  Novel small molecules for the treatment of infections caused by Candida albicans: a patent review (2002 – 2010) , 2011, Expert opinion on therapeutic patents.

[20]  Liangdong Guo,et al.  The first naturally occurring thiepinols and thienol from an endolichenic fungus Coniochaeta sp. , 2010, Organic letters.

[21]  Jonathan M Goodman,et al.  Assigning stereochemistry to single diastereoisomers by GIAO NMR calculation: the DP4 probability. , 2010, Journal of the American Chemical Society.

[22]  R. D. Santo Natural products as antifungal agents against clinically relevant pathogens , 2010 .

[23]  G. Bringmann,et al.  The Assignment of Absolute Stereostructures through Quantum Chemical Circular Dichroism Calculations , 2009 .

[24]  K. Wannemuehler,et al.  Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS , 2009, AIDS.

[25]  Po-Ren Hsueh,et al.  Current challenges in the management of invasive fungal infections , 2008, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[26]  C. Hertweck,et al.  Epicoccarines A, B and epipyridone: tetramic acids and pyridone alkaloids from an Epicoccum sp. associated with the tree fungus Pholiota squarrosa. , 2007, Organic & biomolecular chemistry.

[27]  R. Cox,et al.  Biosynthesis of the 2‐Pyridone Tenellin in the Insect Pathogenic Fungus Beauveria bassiana , 2007, Chembiochem : a European journal of chemical biology.

[28]  David R. Williams,et al.  Total synthesis of (+)-apiosporamide: assignment of relative and absolute configuration. , 2005, Angewandte Chemie.

[29]  M. Richardson,et al.  Changing patterns and trends in systemic fungal infections. , 2005, The Journal of antimicrobial chemotherapy.

[30]  H. Oikawa,et al.  Biosynthetic studies on the antibiotics PF1140: a novel pathway for a 2-pyridone framework , 2005 .

[31]  M. Shibazaki,et al.  YM-215343, a novel antifungal compound from Phoma sp. QN04621. , 2004, The Journal of antibiotics.

[32]  M. Brönstrup,et al.  Coniosetin, a novel tetramic acid antibiotic from Coniochaeta ellipsoidea DSM 13856. , 2003, The Journal of antibiotics.

[33]  M. Hamburger,et al.  Novel tetramic acids and pyridone alkaloids, militarinones B, C, and D, from the insect pathogenic fungus Paecilomyces militaris. , 2003, Journal of natural products.

[34]  J. Clardy,et al.  A cholesteryl ester transfer protein inhibitor from an insect-associated fungus. , 1996, The Journal of antibiotics.

[35]  H. Fujimoto,et al.  Monoamine Oxidase-Inhibitory Components from an Ascomycete, Coniochaeta tetraspora. , 1996 .

[36]  S. Udagawa,et al.  Two new species ofConiochaeta with a cephalothecoid peridium wall , 1995 .

[37]  J. Scott,et al.  Coniochaetones A and B: New antifungal benzopyranones from the coprophilous fungus Coniochaeta saccardoi , 1995 .

[38]  J. Scott,et al.  Apiosporamide, a new antifungal agent from the coprophilous fungus Apiospora montagnei. , 1994, Journal of natural products.

[39]  M. Yamazaki,et al.  Structure of fischerin, a new toxic metabolite from an ascomycete, Neosartorya fischeri var. fischeri. , 1993, Journal of natural products.